Treatment of astrocytoma in Germany
Modern standards of treatment for brain tumors while maintaining quality of life
Astrocytoma is the most common glial tumor of the brain, derived from astrocytes. RheinRegio Klinik Zentrum uses individual treatment protocols based on the molecular genetic characteristics of the tumor. Our goal is the best possible control of the disease while maintaining neurological functions.
Symptoms of astrocytoma
General cerebral manifestations
- Progressive headaches (worsen in the morning)
- Nausea and vomiting without relief
- Epileptic seizures (in 50-70% of patients)
Focal symptoms
- Muscle weakness (if localized in the motor cortex)
- Coordination problems (cerebellar damage)
- Visual disturbances (tumors of the occipital lobe)
- Behavioral changes (frontal lobes)
Important: Pilocytic astrocytomas (grade I) are more common in children, and diffuse forms (grade II and higher) in adults.
Diagnosis of astrocytoma at RheinRegio Klinik Zentrum
At RheinRegio Klinik Zentrum we carry out:
- MRI with perfusion and spectroscopy
- PET with methionine (determination of tumor boundaries)
- Stereotactic biopsy with histology and:
- IDH1/2 status
- MGMT methylation
- TERT mutation
- Liquid biopsy (recurrence monitoring)
Critical: Accurate molecular profiling to guide treatment decisions.
Each direction is supervised by advanced oncologists.
Find out the cost of treatment
To find out the approximate cost of treatment, answer a few questions and we will contact you!
Classification of astrocytomas (WHO, 2021)
According to the degree of malignancy
- Grade I: Pilocytic astrocytoma (benign)
- Grade II: Diffuse astrocytoma (IDH-mutant)
- III degree: Anaplastic astrocytoma
- IV degree: Glioblastoma
By molecular markers
- IDH-mutant: best prognosis
- IDH-wild: aggressive course
Treatment methods for astrocytoma
1. Neurosurgery
- Maximum safe resection with neuronavigation
- Intraoperative MRI control
- 5-ALA fluorescence (for high-grade forms)
2. Radiation therapy
- IMRT (for anaplastic forms)
- Proton therapy (for children)
3. Drug treatment
- Temozolomide (for MGMT methylation)
- IDH inhibitors (for mutant tumors)
- Bevacizumab (for pseudoprogression)
Survival prognosis
- I degree: >95%
- II degree: 60-80%
- III degree: 30-50%
Conclusion: Our clinic uses a personalized approach to each patient with astrocytoma.
Schedule a consultation to develop a personalized treatment plan.
Our clinics
The association of clinics RheinRegio Klinik Zentrum offers the organization of treatment for astrocytoma in Germany without intermediaries, providing access to the country’s leading oncology clinics. We combine advanced techniques, an individual approach and the highest level of medical care, giving hope even in difficult cases.
Why RheinRegio Klinik Zentrum?
- Expert center for gliomas
- Molecular diagnostics
- Organ-preserving technologies
- Clinical studies
